Myriad Genetics finalizes separation agreement with former CFO Scott Leffler; $1.24M severance plus equity acceleration

MYRIAD GENETICS INC

Scott J. Leffler's separation effective Sep 2, 2025; lump-sum severance payment of $1,239,384.
Unvested time-based equity awards scheduled to vest within 2 years accelerated; performance-based awards remain outstanding.
COBRA medical premiums paid by company for up to one year after separation date.
Leffler reaffirms non-compete, non-solicitation, and non-disparagement obligations.
Company provides neutral references; no admission of liability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.